Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-03-17

Clinical Trial Update: Identification of Non-responders to Levothyroxine Therapy [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating identification of non-responders to levothyroxine therapy in hypothyroidism, with biomarker focus.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Levothyroxine (levothyroxine)

Snippet

Sponsor: Oslo University Hospital | Conditions: Hypothyroidism, Biomarkers | Phase 2 | Status: COMPLETED